CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:CGNH
CUSIPN/A
Phone905-673-8501
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares96,050,000
Market Cap$1.39 million
CardioGenics (OTCMKTS:CGNH) Frequently Asked Questions
What is CardioGenics' stock symbol?
CardioGenics trades on the OTCMKTS under the ticker symbol "CGNH."
Who are some of CardioGenics' key competitors?
Some companies that are related to CardioGenics include Janel (JANL), Spindle (SPDL), International Monetary Systems, Ltd. Common Stock (ITNM), SPARTA COMMERCIAL SERVICES Common Stock (SRCO), LiveWorld (LVWD), RightsCorp (RIHT), Net Savings Link (NSAV), Dale Jarrett Racing Adventure, Inc. Common Stock (TVMD), Hydrophi Technologies Group (HPTG), MMRGlobal Inc common stock (MMRF), Prism Technologies Group (PRZM), Invictus Financial Inc. Common Stock (IVFZF), InterCloud Systems (ICLD), Coupon Express Inc. Common Stock (CPXP) and Local (LOCMQ).
Who are CardioGenics' key executives?
CardioGenics' management team includes the folowing people:
- Dr. Yahya Abdul Gawad MB, Ch.B., M.D., MSc., Chief Exec. Officer and Director (Age 60)
- Mr. James A. Essex CA, MBA, Chief Financial Officer (Age 69)
- Ms. Linda J. Stering F.Inst.L.C.O., Sec. and Director (Age 57)
Has CardioGenics been receiving favorable news coverage?
Headlines about CGNH stock have been trending positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CardioGenics earned a daily sentiment score of 0.26 on Accern's scale. They also gave news headlines about the company an impact score of 47.62 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days. View Recent Headlines for CardioGenics.
How do I buy shares of CardioGenics?
Shares of CGNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CardioGenics' stock price today?
One share of CGNH stock can currently be purchased for approximately $0.0143.
How big of a company is CardioGenics?
CardioGenics has a market capitalization of $1.39 million.
How can I contact CardioGenics?
CardioGenics' mailing address is 6295 Northam Drive Unit 8, Mississauga A6, L4V 1W8. The company can be reached via phone at 905-673-8501 or via email at [email protected]
MarketBeat Community Rating for CardioGenics (OTCMKTS CGNH)
MarketBeat's community ratings are surveys of what our community members think about CardioGenics and other stocks. Vote "Outperform" if you believe CGNH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGNH will underperform the S&P 500 over the long term. You may vote once every thirty days.
